GMYPX
Price
$17.56
Change
+$0.08 (+0.46%)
Updated
Aug 13 closing price
Net Assets
431.77M
VVIAX
Price
$70.53
Change
+$0.51 (+0.73%)
Updated
Aug 13 closing price
Net Assets
195.81B
Interact to see
Advertisement

GMYPX vs VVIAX

Header iconGMYPX vs VVIAX Comparison
Open Charts GMYPX vs VVIAXBanner chart's image
Goldman Sachs Large Cap Value P
Price$17.56
Change+$0.08 (+0.46%)
VolumeN/A
Net Assets431.77M
Vanguard Value Index Adm
Price$70.53
Change+$0.51 (+0.73%)
VolumeN/A
Net Assets195.81B
GMYPX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GMYPX vs. VVIAX commentary
Aug 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMYPX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. GMYPX (432M). VVIAX pays higher dividends than GMYPX: VVIAX (2.18) vs GMYPX (1.24). GMYPX was incepted earlier than VVIAX: GMYPX (7 years) vs VVIAX (25 years). GMYPX (0.88) is less costly to investors than VVIAX (0.05). GMYPX is a more actively managed with annual turnover of: 51.00 vs. VVIAX (9.00). GMYPX has a lower initial minimum investment than VVIAX: GMYPX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 9.34 vs. GMYPX (0.52). VVIAX return over 5 years is better than : 67.84 vs. GMYPX (28.81).
GMYPXVVIAXGMYPX / VVIAX
Total Expense Ratio0.690.051,380%
Annual Report Gross Expense Ratio0.880.051,760%
Fund Existence7 years25 years-
Gain YTD4.9856.07782%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets432M196B0%
Annual Yield % from dividends1.242.1857%
Returns for 1 year0.529.346%
Returns for 3 years10.0126.1338%
Returns for 5 years28.8167.8442%
Returns for 10 yearsN/A114.05-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NKTR25.722.12
+8.98%
Nektar Therapeutics
TARS52.721.36
+2.65%
Tarsus Pharmaceuticals
KTTA0.720.02
+2.57%
Pasithea Therapeutics Corp
ITT170.780.79
+0.46%
ITT
CFSB13.930.04
+0.25%
CFSB Bancorp